Risk Factors for Bleeding in Hospitalized at Risk Patients With an INR of 5 or More Treated With Vitamin K Antagonists

Various predictive scores for vitamin K antagonist (VKA)-related bleeding have been developed and validated in outpatients and in patients treated for specific indications (when VKAs are used under optimal therapeutic conditions). However, there are few published data on the evaluation of bleeding r...

Descripción completa

Detalles Bibliográficos
Autores principales: Liabeuf, Sophie, Scaltieux, Lucie-Marie, Masmoudi, Kamel, Roussel, Bertrand, Moragny, Julien, Andrejak, Michel, Gras-Champel, Valérie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
4400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291619/
https://www.ncbi.nlm.nih.gov/pubmed/26717378
http://dx.doi.org/10.1097/MD.0000000000002366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291619/
https://www.ncbi.nlm.nih.gov/pubmed/26717378
http://dx.doi.org/10.1097/MD.0000000000002366

Ejemplares similares